Whitener Capital Management, Inc. Abbott Laboratories Transaction History

Whitener Capital Management, Inc.

$412 Million
Q3 2025

A detailed history of Whitener Capital Management, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Whitener Capital Management, Inc. holds 27,718 shares of ABT stock, worth $3.6 Million. This represents 0.9% of its overall portfolio holdings.

Number of Shares

27,718

Previous 25,818 7.36%

Holding current value

$3.6 Million

Previous $3.51 Million 5.72%

% of portfolio

0.9%

Previous 0.94%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 15, 2025	BUY	$120.51 - $136.62 $228,969 - $259,578	1,900 Added 7.36%	27,718 $3.71 Million
Q2 2025 Jul 14, 2025	BUY	$123.95 - $138.08 $117,504 - $130,899	948 Added 3.81%	25,818 $3.51 Million
Q1 2025 May 01, 2025	SELL	$111.1 - $140.22 $61,105 - $77,121	-550 Reduced 2.16%	24,870 $3.3 Million
Q4 2024 Jan 15, 2025	SELL	$111.93 - $119.39 $78,351 - $83,573	-700 Reduced 2.68%	25,420 $2.88 Million
Q3 2024 Oct 29, 2024	SELL	$100.07 - $118.13 $49,634 - $58,592	-496 Reduced 1.86%	26,120 $2.98 Million
Q2 2024 Jul 17, 2024	BUY	$100.73 - $112.44 $204,985 - $228,815	2,035 Added 8.28%	26,616 $2.77 Million
Q1 2024 Apr 16, 2024	SELL	$109.52 - $120.96 $17,961 - $19,837	-164 Reduced 0.66%	24,581 $2.79 Million
Q4 2023 Jan 10, 2024	SELL	$90.19 - $110.4 $3,337 - $4,084	-37 Reduced 0.15%	24,745 $2.72 Million
Q3 2023 Nov 02, 2023	BUY	$95.53 - $114.62 $9,553 - $11,462	100 Added 0.41%	24,782 $2.4 Million
Q2 2023 Jul 13, 2023	BUY	$100.78 - $112.29 $67,522 - $75,234	670 Added 2.79%	24,682 $2.69 Million
Q4 2022 Mar 01, 2023	SELL	$95.06 - $111.52 $28,518 - $33,456	-300 Reduced 1.23%	24,012 $2.64 Million
Q3 2022 Oct 28, 2022	BUY	$96.76 - $112.03 $19,352 - $22,406	200 Added 0.83%	24,312 $2.35 Million
Q2 2022 Aug 09, 2022	BUY	$102.07 - $123.37 $6,838 - $8,265	67 Added 0.28%	24,112 $2.62 Million
Q1 2022 May 11, 2022	BUY	$114.02 - $139.04 $25,654 - $31,284	225 Added 0.94%	24,045 $2.85 Million
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $2.57 Million - $3.15 Million	22,270 Added 1436.77%	23,820 $3.35 Million
Q4 2021 Feb 07, 2022	SELL	$115.53 - $141.46 $2.27 Million - $2.78 Million	-19,622 Reduced 92.68%	1,550 $218,000
Q3 2021 Nov 12, 2021	SELL	$116.66 - $129.06 $182,339 - $201,720	-1,563 Reduced 6.87%	21,172 $2.32 Million
Q2 2021 Aug 12, 2021	BUY	$105.79 - $124.53 $185,132 - $217,927	1,750 Added 8.34%	22,735 $2.64 Million
Q1 2021 May 11, 2021	SELL	$108.84 - $128.23 $20,353 - $23,979	-187 Reduced 0.88%	20,985 $2.51 Million
Q4 2020 Feb 08, 2021	SELL	$105.0 - $114.42 $67,200 - $73,228	-640 Reduced 2.93%	21,172 $2.32 Million
Q3 2020 Oct 09, 2020	BUY	$91.64 - $111.29 $123,714 - $150,241	1,350 Added 6.6%	21,812 $2.37 Million
Q2 2020 Jul 17, 2020	BUY	$76.57 - $98.0 $94,410 - $120,834	1,233 Added 6.41%	20,462 $1.87 Million
Q1 2020 Apr 24, 2020	BUY	$62.82 - $91.86 $116,217 - $169,941	1,850 Added 10.65%	19,229 $1.52 Million
Q4 2019 Feb 12, 2020	BUY	$78.51 - $87.4 $209,621 - $233,358	2,670 Added 18.15%	17,379 $1.51 Million
Q2 2019 Aug 02, 2019	BUY	$72.88 - $85.0 $36,440 - $42,500	500 Added 3.52%	14,709 $1.24 Million
Q1 2019 May 02, 2019	BUY	$66.22 - $80.06 $6,622 - $8,006	100 Added 0.71%	14,209 $1.14 Million
Q4 2018 Feb 06, 2019	BUY	$65.56 - $74.27 $4,851 - $5,495	74 Added 0.53%	14,109 $1.02 Million
Q3 2018 Nov 07, 2018	BUY	$60.81 - $73.36 $27,364 - $33,012	450 Added 3.31%	14,035 $1.03 Million
Q2 2018 Aug 08, 2018	BUY	$57.57 - $63.54 $5,757 - $6,354	100 Added 0.74%	13,585 $828,000
Q1 2018 Apr 23, 2018	BUY	$56.27 - $63.62 $112,540 - $127,240	2,000 Added 17.41%	13,485 $808,000
Q4 2017 Apr 23, 2018	BUY	$53.68 - $57.47 $616,514 - $660,042	11,485	11,485 $655,000

Others Institutions Holding ABT

# of Institutions

3,649

Shares Held

1.38B

Call Options Held

10.4M

Put Options Held

9.01M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $228B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Whitener Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Whitener Capital Management, Inc. with notifications on news.

Account

Whitener Capital Management, Inc. Abbott Laboratories Transaction History